Obermatt
See Similar Stocks →

Trulieve Cannabis

CNX:TRUL · CA89788C1041
PharmaceuticalsMedium

360

39
Medium confidence — indicative
Profit price39
Cash yield1
Price/Sales57
Price/Book48
Return on Capital39
Cash Return on Capital23
Return on Equity18
EBIT Margin37
Gross Profitability40
Accruals93
Owner Earnings Margin23
Sales growth11
Profit Growth86
Long-Term EPS Growth21
Reinvestment70
Price momentum92
Debt load38
Refinancing76
Debt Payback11
Liquidity86
Analyst ratings75
Expectations trend50
Market mood29
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Trulieve Cannabis clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 4/5 components.

Profile

CountryUSA
IndustryPharmaceuticals
SizeMedium
TypePublic Company
Founded1940
Employees1,650
Websitetrulieve.com
ISINCA89788C1041
Last UpdateApr 2, 2026
Indices
Sound Pay Practices (USA)
Themes
HorticultureCannabisAlternative MedicineHealth CarePharmaceutical

Description

Trulieve Cannabis Corp. (Trulieve) operates as a vertically integrated cannabis company and multi-state operator with operations in nine states. The company is a cannabis retailer in the United States with market-leading retail operations in Arizona…

Analysis

Middle-of-the-road

Trulieve Cannabis Corp. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
69
2023202420252026

All-time high

78

Jan 2023

All-time low

35

Feb 2026

Average rank

56

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
57
87
78
42
Price/Earnings
3
72
72
36
Price/Book
48
84
72
15
Dividend Yield
1
1
1
1
Value (overall)
19
86
72
11

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Trulieve Cannabis with its peers
Curaleaf Holdings
TOR:CURA
14
CountryUSA
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
OrganiGram Holdings
TOR:OGI
39
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
SNDL
NAQ:SNDL
45
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Cresco Labs
CNX:CL
43
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Tronox
NYQ:TROX
3
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →